Real-time disaster intelligence, alerts, and response tools.
Thursday, April 23, 2026
[ad_1] CAMBRIDGE, Mass., Dec. 10, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the appointment of Ron Squarer to its […]
[ad_1] Key Highlights: First-in-human milestone: The inaugural patient has been dosed with PRV131. Precise, localized delivery: Built on Privo’s PRV Platform technology, PRV131 delivers high concentrations of cisplatin directly to tumors, while minimizing systemic exposure. […]
[ad_1] PERU, Ind., Dec. 10, 2025 /PRNewswire/ — Prominently featured in The Inner Circle, Bradley Hammersley, DPM, MSHM is acknowledged as a Pinnacle Lifetime Member for his contributions as a Dedicated Leader and Specialist in […]
[ad_1] NEW YORK, Dec. 10, 2025 /PRNewswire/ — Breast cancer remains one of the most common cancers in the world — but advances in screening, diagnostic tools, and personalized treatment are transforming how patients and […]
[ad_1] PASADENA, Texas, Dec. 10, 2025 /PRNewswire/ – Kaneka Nutrients is advancing its efforts to monitor Ubiquinol product authenticity in response to growing concerns about misleading label claims. As the trusted leader in Ubiquinol production […]
